Cargando…
Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro
Autores principales: | Johnston, Elisha, Emani, Chandrakanth, Kochan, Andrew, Ghebrehawariat, Kidane, Tyburski, John, Johnston, Michael, Rabago, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759605/ https://www.ncbi.nlm.nih.gov/pubmed/33367968 http://dx.doi.org/10.1186/s40634-020-00323-w |
Ejemplares similares
-
Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro
por: Johnston, Elisha, et al.
Publicado: (2020) -
Correction: A protocol for a randomized clinical trial assessing the efficacy of hypertonic dextrose injection (prolotherapy) in chronic ankle instability
por: Sit, Regina Wing Shan, et al.
Publicado: (2023) -
Prolotherapy injections and physiotherapy used singly and in combination for lateral epicondylalgia: a single-blinded randomised clinical trial
por: Yelland, Michael, et al.
Publicado: (2019) -
Prolotherapy: Regenerative Medicine for Lateral Epicondylitis
por: Piraccini, Emanuele, et al.
Publicado: (2020) -
Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: A systematic review and meta-analysis
por: Sit, Regina WS, et al.
Publicado: (2016)